Acadian Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.97M | Buy |
240,264
+82,998
| +53% | +$681K | ﹤0.01% | 834 |
|
2025
Q1 | $1.12M | Buy |
+157,266
| New | +$1.12M | ﹤0.01% | 910 |
|
2024
Q4 | – | Sell |
-133,817
| Closed | -$1.4M | – | 2070 |
|
2024
Q3 | $1.4M | Buy |
133,817
+91,525
| +216% | +$959K | ﹤0.01% | 845 |
|
2024
Q2 | $494K | Buy |
+42,292
| New | +$494K | ﹤0.01% | 1200 |
|
2023
Q1 | – | Sell |
-21,873
| Closed | -$494K | – | 1929 |
|
2022
Q4 | $494K | Buy |
+21,873
| New | +$494K | ﹤0.01% | 1036 |
|
2022
Q3 | – | Sell |
-17,804
| Closed | -$440K | – | 1815 |
|
2022
Q2 | $440K | Buy |
+17,804
| New | +$440K | ﹤0.01% | 1013 |
|
2019
Q3 | – | Sell |
-9,778
| Closed | -$503K | – | 1981 |
|
2019
Q2 | $503K | Sell |
9,778
-98,845
| -91% | -$5.08M | ﹤0.01% | 1019 |
|
2019
Q1 | $6.23M | Buy |
108,623
+88,300
| +434% | +$5.06M | 0.03% | 392 |
|
2018
Q4 | $853K | Sell |
20,323
-26,084
| -56% | -$1.09M | ﹤0.01% | 779 |
|
2018
Q3 | $3.5M | Sell |
46,407
-24,459
| -35% | -$1.85M | 0.01% | 443 |
|
2018
Q2 | $5.08M | Buy |
+70,866
| New | +$5.08M | 0.02% | 383 |
|
2017
Q2 | – | Sell |
-14,107
| Closed | -$272K | – | 1558 |
|
2017
Q1 | $272K | Buy |
+14,107
| New | +$272K | ﹤0.01% | 996 |
|